Global Burden of Disease Study 2025
The GBD study offers a powerful resource to understand the changing health challenges facing people across the world in the 21st century. Led by the Institute for Health Metrics and Evaluation (IHME), the GBD study is the most comprehensive worldwide observational epidemiological study to date. By tracking progress within and between countries GBD provides an important tool to inform clinicians, researchers, and policy makers, promote accountability, and improve lives worldwide.
Global mortality rates are falling but not among youths and young adults, according to the latest Global Burden of Disease (GBD) study published in The Lancet on October 12th. Additionally, non-communicable diseases (NCDs) now account for nearly two-thirds of the world’s total mortality and morbidity, with ischemic heart disease, stroke, and diabetes leading the globe. Researchers also estimate that nearly half of all death and disability could be prevented by modifying some of the leading risk factors, such as reducing high levels of blood sugar and high body mass index (BMI).
Global life expectancy in 2023 is more than 20 years higher compared to 1950, and the age-standardized mortality rate is 67% lower, with all 204 countries and territories reporting declines.
Despite these improvements, the world faces an emerging crisis of higher death rates in adolescents and young adults in North America and Latin America due to suicide and drug and alcohol consumption and in sub-Saharan Africa due to infectious diseases and unintentional injuries.
www.praeventionstag.de